These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cervical cancer audit: and what is quality? Wilson PO Cytopathology; 2002 Jun; 13(3):141-4. PubMed ID: 12060075 [No Abstract] [Full Text] [Related]
25. [Diagnostic variability versus diagnostic errors in cytology]. Dalla Palma P Pathologica; 2001 Oct; 93(5):593-5. PubMed ID: 11725366 [No Abstract] [Full Text] [Related]
26. Intraobserver and interobserver variability in the quality assessment of cervical smears. Klinkhamer PJ; Vooijs GP; de Haan AF Acta Cytol; 1989; 33(2):215-8. PubMed ID: 2929223 [TBL] [Abstract][Full Text] [Related]
27. Improving the adequacy of Pap smears. Baker RM Am Fam Physician; 1989 Jun; 39(6):109-14. PubMed ID: 2729036 [TBL] [Abstract][Full Text] [Related]
28. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"]. Calvache AE Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849 [No Abstract] [Full Text] [Related]
29. [Quality of vaginal smear for cervical cancer screening: a concordance study]. Cendales R; Wiesner C; Murillo RH; Piñeros M; Tovar S; Mejía JC Biomedica; 2010; 30(1):107-15. PubMed ID: 20890555 [TBL] [Abstract][Full Text] [Related]
30. ["Papanicolaou." Outmoded, isn't it?]. de León-Antoni E Bol Asoc Med P R; 1991 Oct; 83(10):462-4. PubMed ID: 1789893 [TBL] [Abstract][Full Text] [Related]
31. An overview of the College of American Pathologists' programs in surgical pathology and cytopathology. Data summary of diagnostic performance in cervical cytopathology. Penner DW Acta Cytol; 1989; 33(4):439-42. PubMed ID: 2750431 [TBL] [Abstract][Full Text] [Related]
32. Pitfalls in the screening and early diagnosis of cervical cancer. Wain GV; Hacker NF Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310 [No Abstract] [Full Text] [Related]
33. Reducing mortality due to cervical cancer. PAPNET fails the test. Melnikow J; Nuovo J Arch Fam Med; 1999; 8(1):56-7. PubMed ID: 9932073 [No Abstract] [Full Text] [Related]
34. Rescreening for quality control in cytology. Melamed MR Acta Cytol; 1996; 40(1):12-3. PubMed ID: 8604563 [No Abstract] [Full Text] [Related]
35. Review of negative Papanicolaou tests: is the retrospective 5-year review necessary. Rubio CA Am J Clin Pathol; 1994 Aug; 102(2):266. PubMed ID: 8042598 [No Abstract] [Full Text] [Related]
37. Effect of circulation and discussion of cervical smears on agreement between laboratories. Ronco G; Montanari G; Confortini M; Parisio F; Berardengo E; Delpiano AM; Arnaud S; Campione D; Baldini D; Poll P; Lynge E; Mancini E; Segnan N Cytopathology; 2003 Jun; 14(3):115-20. PubMed ID: 12828719 [TBL] [Abstract][Full Text] [Related]
38. Technology and process and cervical cancer prevention. Raab SS; Grzybicki DM Am J Clin Pathol; 2008 Feb; 129(2):187-9. PubMed ID: 18208797 [No Abstract] [Full Text] [Related]
39. Statistical analysis of data in cervical cytology from the viewpoint of total quality management. Kaminsky FC; Burke RJ; Haberle KR; Mullins DL Acta Cytol; 1995; 39(2):222-31. PubMed ID: 7887069 [TBL] [Abstract][Full Text] [Related]
40. Does cervical cancer screening do more harm than good? Payne L; Lavis P Nurs Times; 2001 Jul 19-25; 97(29):20. PubMed ID: 11957496 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]